SCHEMBL23664164

SCHEMBL23664164

O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(Cl)c(-c2cnc3c(c2)C(=O)NC3)c1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23664099 0.89 ABL1 (0.56) ABL1
SCHEMBL23664190 0.87 ABL1 (0.62) ABL1
SCHEMBL23664103 0.85 ABL1 (0.72) ABL1
SCHEMBL23664118 0.85 ABL1 (0.69) ABL1
SCHEMBL23664135 0.84 ABL1 (0.71) ABL1
SCHEMBL23664156 0.83 ABL1 (0.73) ABL1
SCHEMBL23664166 0.83 ABL1 (0.64) ABL1
SCHEMBL23664136 0.83 ABL1 (0.50) ABL1
SCHEMBL23664168 0.83 ABL1 (0.64) ABL1
SCHEMBL23664175 0.83 ABL1 (0.73) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021143927-A1 COMPOUND ACTING AS BCR-ABL INHIBITOR 正大天晴药业集团股份有限公司 2021-07-22 — — WO disclosed
Send feedback